Laura Blair explains why streamlining the patient journey via and simpler tools help ensure adherence from the point of prescription. Laura Blair discusses what makes enrollment friction, and how the ...

Rahul Shah and Mack MacKenzie explain how to unlock the ROI that rules-based systems have left on the table.

Erez Israeli explains how Dr. Reddy's approached commercial readiness for its generic semaglutide launch in Canada and what vertical integration in peptide manufacturing means for the GLP-1 market.

ORBIS' Matt Marchetti outlines how pharma companies can define supply chain impact, KPIs, and ROI when transitioning to reusable plastic pallets. By prioritizing solutions such as reusable plastic ...

AI-driven cold chain visibility is only as reliable as the data behind it, exposing gaps between compliance, monitoring, and true product conditions.

Continuous in-transit monitoring shifts cold chain control from post-delivery forensics to proactive intervention, enabling rerouting, expedited handoffs, and mid-journey coolant replenishment before ...

Brent Wilhelm of Cencora discusses why available inventory still leads to shortages, and how tighter distributor-manufacturer integration and AI could close the gap. In part 1 of a 3-part interview ...

Episode 1 of Supply Chain Signal breaks down the FDA's PreCheck pilot, the US Section 301 probe into German drug pricing, and CMS's move to make Medicare drug price negotiation permanent. The debut ...

PwC's Roel van den Akker says pharma M&A ran beyond expectations in the first half of 2026, with dealmaking potentially on pace to hit $300 billion in H2. Pharmaceutical Commerce recently checked in ...

Lilly will pay $6.75 per share (~26% premium), totaling $2.8 billion upfront with up to $1 billion milestone-based consideration, and expects closure in Q3 2026. Federal acceleration of psychedelic ...

In this week's Pharma Pulse, CVS Caremark settles with the FTC over rebates and TrumpRx, Germany more than doubles its drug rebate, and the FDA proposes a registration rule. Welcome to Pharma Pulse, a ...